Center-Authored Papers

Filters: Author is Kuderer, Nicole M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2014
Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH.  2014.  Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.. Cancer medicine. 3(2):434-44. Abstract
Kuderer NM, Lyman GH.  2014.  Guidelines for treatment and prevention of venous thromboembolism among patients with cancer.. Thrombosis research. 133 Suppl 2:S122-7. Abstract
Adolescent
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Adult
Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.  2006.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.. Cancer. 106(10):2258-66. Abstract
Kuderer NM, Dale DC, Crawford J, Lyman GH.  2007.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(21):3158-67. Abstract
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Aged
Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.  2006.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.. Cancer. 106(10):2258-66. Abstract
Lyman GH, Kuderer NM, Balducci L.  2002.  Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients.. Current opinion in hematology. 9(3):207-14. Abstract
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.  2007.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.. Cancer. 110(10):2339-46. Abstract
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.  2008.  Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood. 111(10):4902-7. Abstract
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.  2006.  Thromboembolism in hospitalized neutropenic cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3):484-90. Abstract
Aged, 80 and over
Lyman GH, Kuderer NM, Balducci L.  2002.  Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients.. Current opinion in hematology. 9(3):207-14. Abstract
Animals
Lyman GH, Kuderer NM.  2011.  Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.. Cancer treatment and research. 157:167-78.
Anticoagulants
Lyman GH, Khorana AA, Kuderer NM, Lee AY.  2009.  Cancer and thrombosis: back to the future renewed interest in an old problem.. Cancer investigation. 27(5):472-3. Abstract
Lyman GH, Kuderer NM.  2010.  Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.. Thrombosis research. 125 Suppl 2:S120-7.
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H et al..  2007.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(34):5490-505. Abstract
Kuderer NM, Khorana AA, Lyman GH, Francis CW.  2007.  A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.. Cancer. 110(5):1149-61. Abstract
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW et al..  2015.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(6):654-6. Abstract
Antineoplastic Agents
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Kuderer NM, Lyman GH.  2011.  Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.. Journal of the National Cancer Institute. 103(12):910-3.
Lyman GH, Kuderer NM.  2002.  Filgrastim in patients with neutropenia: potential effects on quality of life.. Drugs. 62 Suppl 1:65-78. Abstract
Lyman GH, Kuderer NM.  2003.  Cost effectiveness of myeloid growth factors in cancer chemotherapy.. Current hematology reports. 2(6):471-9. Abstract
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.  2008.  Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood. 111(10):4902-7. Abstract